Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Proteoformics; a New Dimension in Protein Diagnostics
Fred Regnier
Purdue Professor, CEO of Novilytic

DescriptionY/NSource
GrantsyesNIH funded SBIR
SalaryyesSalary from the SBIR
Board MemberyesThe boards of Perfinity, Novilytic, and Moderna
Stockyes Perfinity, Novilytic, adn Moderna
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no